|
Real-time Estimate
Cboe BZX
03:26:57 01/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 525.64 USD | -0.21% |
|
+1.55% | +15.66% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | -0.41% | +1.55% | +15.66% | +33.88% | +189.07% | 134B |  |  | |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
